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Summary: The circadian rhythm in the urinary excretion of etioeholanolone, of androsterone and of dehydroepi-
androsterone in normal menstruating women was studied.
The excretion patterns of etiocholanolone and androsterone seem to be nearly synchronous, but not equal, thus
resulting in a diurnal Variation.
Einige Aspekte des circadianen Rhythmus der Ausscheidung von Etiocholanolon, Androsteron
und Dehydroepiandrosteron im Harn
Zusammenfassung: Der circadiane Rhythmus in der Ausscheidung von Etiocholanolon, Androsteron und Dehydro-
epiandrosteron im Harn normal menstruierender Frauen wurde untersucht.
Die Ausscheidungsmuster von Etiocholanolon und Androsteron scheinen nahezu synchron zu sein, aber nicht gleich
und zeigen somit eine diurnale Variation.
Introduction
1t is known that the urinary excretion of 17-oxo-
steroids occurs in a circadian rhythm (1). Since dehydro-
epiandrosterone1), etiocholanolone and androsterone
are quantitatively the most important 17-oxosteroids,
it is obvious to suppose that this rhythm is caused by
one or more of them. In the case of the latter the ques-
tion arises whether the circadian rhythm is parallel for
each steroid, or whether the relative proportions of the
excretion pattern vary during 24 hours. This may be of
importance since in several publications the etiochol-
anolone/androsterone ratio, calculated from the uriftary
steroid excretion pattern, is mentioned äs parameter
separate from other parameters for some pathological
syndromes. The etiocholanolone/androsterone ratio is
increased in patieüts with Cushing's syndrome (2), and in
Sor-reduetase deficiency (3);it is decreased in patients
with hyperthyreoidism (4,2), in the Stein Leventhal
syndrome (5, 6), and in adrenoblastome (7). Keutmann
(4) considers an etiocholanolone/androsterone ratio of
about l .0 äs normal for woman at age 20 years, and he
fmds that the ratio slowly increases with age. Moolenaar






(2) reports a reference value of 0.90 ± 0.22 (mean ±
SD) for normal women in the age ränge 19-44 years. In
our laboratory we found etiocholanolone/androsterone
ratios between 0.7 and 1.3 (± 2 SD); these were cal-
culated from the urinary steroid excretion pattern, ob-
tained by the method of Van Kämpen (8).
This publication describes our investigation on the
existence of a diurnal Variation of the urinary excretion
of etiocholanolone, androsterone and dehydroepi-
androsterone, and the interrelationship of these rhythms.
For this purpose the steroid excretion patterns in the
urine of 8 normal women, aged between 20 and 37 years,
were analysed. The urine was collected in portions of
8 hours covering 24 hours. Urine collection was moni-
tored by the determination (9) of urinary creatinine.
Materials and Methods
Materials
Eight normal feraale volunteers in the age ränge 20-37 years
participated in this investigation. They made know that they
either never used oral contraceptives or had stopped the intake
öf them at least three months bofore the beginning of the tests.
During two days in the follicular phase and during two days in
the luteal phase of the menstrual cycle they collected their
urine. This was done in 8 hour samples (I: 07.00-15.00 h,
: 15.00-23.00 h, Hl: 23.00-07.00 h). From each of these
samples a part in proportion to the volume was taken and mixed
to give sample IV (07.00-07.00 h). The urincs were kept at
4 °C until analysis, \vhich was performed within l week. Samples
I, II, III and IV of one volunteer were analysed in one series.
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M e t h o d s
The urinary stcroid excretion patterns wcre determined in tvvo
1) The acidic hydrolysis was pcrformed äs describcd by Rubens
(6). This compriscd t\vo liydrolyses in diffcrent acidic raedia.
a) The hydrolysis of urinary steroid estcrs is accomplished in a
Stroms acidic medium (earlier described by Van Kämpen (8)).
Steroids thus liberated are cxtracted from the aqueous phase by
1,2-dichloroethane simultaneously present in the r.eaction tube.
The dichlorocthane phase is separated from the aqueous phase
and washcd with demineralized water. The dichloroethane is
evaporated. The extract of the steroids is dissolved in an ethanolic
solution of cholestanone1) (40 mg/1, internal Standard). The
gas liquid chromatography Separation was performed with a
Hewlett-Packard 5750 Instrument equipped with a flame ioniza-
tion detector and with two glass columns, packed with 3.8%
SE 30 on chromosorb W-AW-DMCS (80-100 mesh). The tem-
pcrature of the columns is programmed (200-250 °C). Chro-
rnatograms obtained by this method show two dominant peaks,
rcprescnting etiocholanolone and androsterone plus dehydro-
epiandrosterone, and a peak of cholestanone. The areas of these
peaks are calculatcd.
The contents of etiocholanolone and androsterone plus de-
hydroepiandrosterone are derived by comparing these areas.
b) A second urine sample was hydrolyzed in a weakly acidic
medium (pH: 4.7) in such a manner that only dehydroepi-
androsteronc sulphate was hydrolyzed äs earlier described by
Jayle (10). After the hydrolysis dehydroepiandrosterone was
extracted by l ,2-dichloro'ethane. The dichloroethane phase was
separated from the aqueous phase and washed with demineralized
water. The dichloroethane was evaporated. The extract of de-
hydroepiandrosterone was treated in the same way äs described
under a. By subtracting the content of dehydroepiandrosterone
from the sum of androsterone plus dehydroepiandrosterone the
content of androsterone may be calculated.
The within-run precision for etiocholanolone is 5.2%, for
androsterone and dehydroepiandrosterone 4% and for dehydro-
epiandrosterone (method b) 3.9%.
The between day precision for etiocholanolone is 6.9%, for
androsterone and dehydroepiandrosterone 6.0% and for de-
hydroepiandrosterone 5%.
Although not investigated extensively, the good correlation
between the methods mentioned under l and 2 indicates that
the methods are accurate.
2) The enzymatic hydrolysis and solvolysis of the steroid esters
were performed according to Burstein (11). The extraction, the
preparation and the gas liquid Chromatographie Separation of
the trimethylsilyl ethers of the steroids Were performed äs
described by Moolenaar (2).
The creatinine content of the urinary portions was determined
by continuous flow analysis by means of the reaction ofJaffe
(12). The within-variability of this method is 2%.
The ovulation in the menstrual cycle was checked by measuring
the basal tempcrature of the volunteers. Since pregnanediol1) is
also measured in the steroid excretion pattern by the above
described method 1), the ovulation could also be established by
the increasc of pregnanediol.
The dala wcre evaluated statistically by the Wilcoxon^ test (13).
Results
All female volunteers had a biphasic basal temperature
curve. Also the rise of the pregnanediol content of the
urine in the luteal phase showed that the ovulation had
occurred.
In table l the results of the creatinine excretions are
given, in particular the number, the ränge and the mean
of the excretions in the follicular phase and in the luteal
phase.
In table 2 the results of the excretion of etiocholanolone,
of androsterone and of dehydroepiandrosterone are
given, in particular the number, the ränge and the mean
of the excretions in the follicular and luteal phase.
The rängei mean and the number of ariälyses of the etio-
chplanolone/androsterone rätio of the urinary samples
in the follicular and in the luteal phase are given in
table 3.
The results mentioned in table 2 and 3 are obtained with
the acidic hydrolysis. In table 4 the results of the en-
zymatic hydrolysis (method 2) are given. These urinary
portions are from two worrien, 3 portions in the follic-
ular phase and 3 in the luteal phase of the menstrual
cycle.
Discussion
The creatinine excretion (table i) is slightly but signiil·
cantly (P < 0.01) gfeater in the luteal phase than in -the
follicular phase of the menstrual cycle. Also is found
that the creatinine excretion in sample II (15.00—
23.00 h) is higher than the excretion in samples I
(P < 0,02) and III (P < 0.01). There is no significant
difference in the excretion in samples I and ( > 0.1).
The results of etiocholanolone and dehydroepiandro-
sterone excretions (table 2) show no defconstrable differ-
ences (P > 0.10 and P > 0.10 respectively) in excretion
in the follicular phase and in the luteal phase. The excre-
tion of androsterone is slightly but significantly
(P < 0.02) highex in the luteal phase than in the follicular
phase. There is an indication that the excretion of
etiocholanolone, of androsterone and of dehydroepi-
androsterone occurs in a circadian rhythm. The excre-
tion of etiocholanolone and of androsterone in sample l
(07.00-15.00 h) is significantly higher (P < 0-.01) than
in sample II, the latter being significantly Mgher
(P < 0.01) than in sample III. The excretion of de-
Tab. l. The number, the ränge and the mean of creatinine excretion (absolute values) in the föllicüiär and in the luteal phase.
Sample
I (07.00-1 5.00 h)
II (15.00-23.00 h)
III (23.00-07.00 h)
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Tab. 2. The number, the r nge and the mean of the excretion of etiocholanolone, androsterone and dehydroepiandrosterone (abso-








































































































Tab. 3. All values of the etiocholanolone/androsterone ratio
(μπιοΐ/μιηοΐ) of the 8-hour urinary samples.
Etiocholanolone/androsterone ratio
Per- Sa m- Follicular phase




















































































































































































χ = These urinary samples were not collected.
hydroepiandrosterone in sample I is not significantly
different (P > 0.10) from the excretion in sample II.
The latter, however, is significantly higher (P < 0.01)
than the excretion in sample III. The observed Variation
does not correspond to the observed Variation in the
excretion of creatinine.
The differences between the etiocholanolone/andro-
sterone ratios of the urinary samples, collected during
two days in the follicuiar phase are not significant
(P > 0.1) · the sarne true in the luteal phase (P > 0.1)
(table 3). There is a small but significant difference
Tab. 4. Absolute values for the excretion of etiocholanolone,
androsteronc and dehydroepiandrostcrone, and the
etiocholanolone/androsterone ratio of 3 urinary samples
in the follicular phase and of 3 urinary samples in the

























































(P < 0.05) between the etiocholanolone/androsterone
ratlos of the samples in the follicuiar and in the luteal
phase.
The etiocholanolone/androsterone ratio of sample I is
significantly higher (P < 0.01) than the etiocholanolone/
androsterone ratio of sample II and the latter is signif-
icantly lower (P < 0.01) than sample III. Between the
etiocholanolone/androsterone ratios of samptes I and III
there is no demonstrable difference (P > 0.10). Figure l
shows clearly this rhythm of the etiocholanolone/andro-
sterone ratio.
Dehydroepiandrosterone is the principal precursor of
etiocholanolone and of androsterone. It is synthesized
and secreted by the adrenal cortex and by the ovary (14).
The formation of etiocholanolone and androsterone
occurs via androstenedione by reduction of the double
bond between the rings A and B. This reduction is
catalyzed in the liver by the A4-steroid-5j3-reductase(s)
localized in the cytosol and the A4-steroid-5a-reductase(s)
of the rnembranes of the endoplasmic reticulum (3,15).
The synthesis and secretion by the adrenal cortex and
the ovary are controlled by the pituitary by means of
corticotropin and lutropin, follitropin respectively. The
J. din. Chem. Clin. Biochem. / Vol. 20,1982 / No. l



















Fig. l. From each of the eight volunteers (a-h) the mean values
of the etiocholanolone/androsterone rätio öf the urinary
samples in the follicular and in the luteal phase are
shown.
observed Variation in the excretion of etiocholanolone
and androsterone can be explained by the demonstrated
diurnal rhythm for corticotropin (16), and for lutropin
and follitropin ((17), only 25 normal children aged 12
to 15 were involved in the investigation).
Our results indicate a greater excretion of androsterone
in the luteal phase of the menstrual cycle. A higher level
of androstenedione in the plasma in the post-ovulatory
phase äs cornpared with the pre-ovulatory phase has
been described (18). The activity of the A4T^-oxo-C19
steroid-Sa-reductase, present in the human ovary (19),
might also be different in the two phases of the men-
strual cycle. The observed Variation in the etiocholano-
lone/androsterone ratiö cannot be explained by the
rhythm of the pituitary hormones. One reason might
be a possible difference in the reactiori rate of the 5 -
reduction and the 5j3-reduction iii the liver. The 5 -
reductase in the hepatocyte is said to be stimulated by
the thyroid hormones (2). Diurnal fluctuations in the
thyroxine level of plasma are known (20). Another
reason might be a diurnal Variation of the aetivity of
5a-reductase in the human ovary. In addition, there
could be a difference in the rate of conjugation of
etiocholanolone with glucuronic acid, and of andrö-
sterone with sulfuric and glücuronic acid, which are
necessary for their excretion in urine.
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